Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
about
The Arctic Human Health Initiative: a legacy of the International Polar Year 2007-2009.Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated populationRationale of using different biological therapies in rheumatoid arthritis.A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitorComparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases.Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.The risk of tuberculosis in patients treated with TNF antagonists.Adverse effects of golimumab in the treatment of rheumatologic diseases.Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.A case of preventable pulmonary tuberculosis in a Greenlandic, heavily immune suppressed patient.Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.Usefulness of two interferon-γ release assays for rheumatic disease.Quantiferon test for tuberculosis screening in sarcoidosis patients.Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infectionInterferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in KoreaThe continuing search for Mycobacterium tuberculosis involvement in sarcoidosis: a study on archival biopsy specimensUsefulness of anin-vitrotuberculosis interferon-γ release assay (T-SPOT.TB) in the first-line check-up of uveitis patientsInterferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment
P2860
Q30393276-52D08697-CBFB-477A-B09A-5C466E9FE6C2Q33518054-37220DFB-1A72-4834-8A93-28370FAA37E9Q34153073-1179F330-B813-4F68-AF98-E987B48B73B2Q34709566-19E0C033-7D03-4E2B-BD45-10F97832951EQ35598203-615E0C0F-BC36-4BC2-BF2C-411563CDFBDDQ35810573-DC5292D9-FD4E-4A7A-A1E8-C0939FB3A34BQ35993903-8200936E-F4BA-4431-9ADC-E0E684363E6DQ37467519-19428878-1FBB-42E2-960D-27B819BC2BA7Q37877262-C20A8922-AEE5-4428-8181-8C9FA28B6462Q38132273-074EE61C-9B89-4452-9EB8-7908B2DE0796Q38265740-5C0AEA02-0914-480D-9D44-0801BCE379D0Q38661516-53ECF455-0D7F-432B-90A4-97BA99C6DE22Q41606424-D5944C4D-74B0-4424-AE1C-2E1CF5CD0E68Q41944517-F9AD8D36-77C9-468E-826C-F5AF2E059D45Q45095583-50617F7B-1B89-491E-A14C-0DF2C4AE636BQ53248630-90375216-AACC-4B07-B60D-051BFC614B97Q53915829-8AEABD38-E5C4-4499-9200-56704E1BB206Q56974048-6E9AE612-D05A-45BC-95C2-4D167C7F9C9EQ57226040-BC4D7CE6-49FF-4AD2-9FE5-4AADFB62BE24Q57283960-63386F98-3BC1-4CB5-A3F6-90F664950425Q58277106-7AB08841-1BD1-4C85-B4E3-0A55034E3AD9Q58924832-5EDC08FB-E5D6-4F0D-A3CE-CAD04ACD509B
P2860
Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparison of screening proced ...... ts with inflammatory diseases.
@en
Comparison of screening proced ...... ts with inflammatory diseases.
@nl
type
label
Comparison of screening proced ...... ts with inflammatory diseases.
@en
Comparison of screening proced ...... ts with inflammatory diseases.
@nl
prefLabel
Comparison of screening proced ...... ts with inflammatory diseases.
@en
Comparison of screening proced ...... ts with inflammatory diseases.
@nl
P2093
P356
P1476
Comparison of screening proced ...... ts with inflammatory diseases.
@en
P2093
Aase Bengaard Andersen
Bolette Soborg
Dorte Vendelbo Jensen
Jan Wohlfahrt
Morten Ruhwald
Nils Milman
Pernille Ravn
Søren Jacobsen
Vibeke Ostergaard Thomsen
P304
P356
10.3899/JRHEUM.081292
P407
P577
2009-07-31T00:00:00Z